Cannabidiol (CBD) is a substance present in Cannabis and is an antagonist of THC. Recently studies demonstrated various effects mainly due to cannabinoids (mainly THC and CBD) which are contained in different proportions depending on the varieties, but also terpenes. The cannabinoid which recently interests the medical environment is the cannabidiol (CBD). Indeed, until recently the interest in Cannabis mainly concerned THC, or 9-tetrahydrocannabinol, and the majority of the existing varieties of Cannabis contained a lot of THC and little CBD. People did look for the 'stoned' effect and 'got high' with THC. More about CBD on Wikipedia, or on recommendations from the web.
a list of CBD / Hemp / Cannabis / THC related articles
Synthetic vs. Whole Plant CBD?
Published in the journal Pharmacology & Pharmacy (Feb. 2015), the article directly challenges one of the sacred cows of Big Pharma and the medical-industrial complex -- the notion that “crude” botanical preparations are inherently low grade and less effective than pure, single-molecule compounds. - https://www.projectcbd.org/article/synthetic-vs-whole-plant-cbd
CBD & THC ratio ?
Understanding the cannabinoids Synergies between CBD:THC. High therapeutic potential use: anti-psychotic, relaxing, used in epilepsy treatments - http://www.alpha-cat.org/resources/understand-and-interpret-the-cbd-thc-ratios/
What's CBD-rich cannabis good for? While a CBD-dominant cannabis remedy with little THC is not intoxicating, it’s not necessarily the most effective treatment option. That’s because CBD and THC can amplify each other’s therapeutic effects. - https://www.cbd.org/patient-guidance-care-by-design
The Entourage Effect
The interaction of various compounds in marijuana is known as the ‘entourag effect. - http://www.leafscience.com/2014/09/11/medical-marijuana-entourage-effect/
For scientific references, it is best to refer to the following databases:
- In English from the USA, US National Library of Medicine (keyword “Cannabidiol”)
- In French, Association International pour le Cannabis Médical
Health and Prevention
press release from addiction suisse
CBD is on everyone’s lips and raises many questions. What is CBD? In what form is it available and what is its effect? What do we know about the risks and what is the legal status? Addiction Switzerland gives answers in a new fact sheet.
Cannabis low in THC and other CBD-based products are being sold legally in a growing number of stores. This (apparent) contradiction between “cannabis” and “legal” leads to uncertainties. And the fact that these products are intended for very different uses is not so easy to accept. This is why Addiction Switzerland has published a fact sheet that gathers the available information on CBD-based products.
Cannabis that is low in THC (less than 1%) is not subject to the Narcotic Drugs Act. However, it cannot be offered as a medicine or as a liquid for the e-cigarette. CBD is thought to have a relaxing effect without causing drunkenness, but the long-term effects are still poorly understood. Although CBD, compared to THC-rich cannabis, is a product with lower health risks, caution should be exercised, especially when it is smoked, as combustion produces harmful substances. Road users should give up CBD because it is difficult to estimate when the legal limit of 1.5 micrograms of THC per litre of blood is reached.
Tel.: 021 321 29 75
press release from GREA
A report from the RTS shows that the boom of this “light” hemp is disturbing the police. Solution: the regulation of cannabis, according to professionals.
The CBD boom, which contains less than 1% THC, is not regulated by the Narcotics Law. The police say they are annoyed, according to a report on RTS in Nouvo on 5 March. For addiction circles, this is an additional issue that comes up in the debate. They believe that a solution will only be found within the framework of cannabis regulation.